Related Experiment Video
Updated: May 1, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Linking cognition and frailty in middle and old age: metabolic syndrome matters
Feng Lin1, Rachel Roiland, Ding-Geng Din Chen
1School of Nursing, University of Rochester, Rochester, NY, USA; Department of Psychiatry, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA.
Objectives:
This study examined whether metabolic syndrome (MetS) would moderate the association of cognition with frailty in middle and old age.
Methods:
A cross-sectional design was used. Six hundred and ninety participants (age ≥ 50 years) from an on-going national survey were included in the study. Confirmatory factor analysis was applied to determine latent variables of executive function (EF), episodic memory (EM), and MetS based on relevant measurements. Frailty was defined using a modified form of Fried's criteria.
Results:
Applying structural equation modeling, having MetS significantly increased the likelihood of being frail. Better performance on EM tasks, but not EF, was significantly associated with lower likelihood of MetS. Worse performance on EF, but not EM, significantly increased the likelihood of being frail. There was a significant interacting effect between MetS and EF, but not EM, on frailty. Further contrast analysis indicated that having MetS strengthened the negative association between EF and frailty.
Conclusion:
Metabolic syndrome moderates the relationship between EF and frailty. A prospecitve study is needed to validate such relationships before developing interventions targeting the prevention or treatment of EF and frailty in individuals with MetS.
Related Concept Videos
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cognitive Development During Adulthood
Mitochondria
Development of Human Microbiota
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Alzheimer Disease l: Introduction

